SESSION TITLE: Lung Cancer IV
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM
PURPOSE: Identifying the normal variants of chromosome alterations in order to generate biomarkers for early stage lung cancer may help patients receive a timely diagnosis and therapies.
METHODS: In this pilot study, we collected 30 tumor samples from non-smoking patients who were diagnosed with lung adenocarcinoma in clinical phase IA-IIB and underwent lobectomies. A total of 23 female patients with a mean age of 57.4 years old, and 8 male patients, with a mean age of 62.8 years old, comprised the participants in this cohort. The DNA was isolated from their tumor tissue and array comparative genomic hybridization (array CGH) was performed using Agilent’s array platform Sureprint 2x400K.